Dudediligence.

Liminatus Pharma, Inc

LIMNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$601,372Sep ’24−$229,752Dec ’24−$327,526Mar ’25$113,287Jun ’25−$1.8MSep ’25−$8.2MDec ’25−$1.1MMar ’26−$1.4MJun ’26
Fiscal years, by the month each ended
LineDec 2024Dec 2025
Operating income−$3.3M−$3.0M
Net income−$3.5M−$10.2M
Operating cash flow−$1.5M−$10.0M
Free cash flownone on file−$10.0M
Debt$20.0M$1.4M
Shares outstanding17.5M27.1M